Effexor, Nasacort AQ, Vigamox Paragraph IV Certification Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Wyeth's antidepressant Effexor (venlafaxine hydrochloride) was filed in November, according to FDA's list of updated filings
You may also be interested in...
Effexor XR To Go Generic In 2010 Under Settlement Between Teva and Wyeth
The deal could give Wyeth more breathing room to launch its follow-on antidepressant.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.